LDCA (Cat No.:I043371) is a synthetic compound with antioxidant properties, primarily used in research to explore its potential therapeutic applications. It combines lipoic acid and dihydroxyphenylacetic acid, both of which are known for their ability to neutralize reactive oxygen species (ROS). LDCA is being studied for its potential in managing oxidative stress-related conditions, such as neurodegenerative diseases, cardiovascular disorders, and metabolic syndromes. Its ability to improve cellular function and reduce inflammation makes it a promising candidate for further investigation in the field of regenerative medicine and disease prevention.